structures of the various synthesized compounds were assigned on the basis of elemental analyses, IR, 1 H NMR, 13 C NMR, and mass spectral data. These compounds were screened for their antimicrobial activity [20] [21] [22] and the results were reported.
MATERIAL AND METHODS
Melting points were determined on a capillary melting point apparatus and are uncorrected.
1 H NMR and 13 C NMR spectra were recorded in the indicated solvent on Bruker AMX 400 MHz spectrophotometer using TMS as an internal standard. Infrared spectra were recorded in KBr on Perkin-Elmer BXF1 spectrophotometer. Microanalyses were performed on carlo Ebra 1108 element analyzer and were within the ± 0.5% of the theoretical values. Column chromatography was performed on silica gel (Merck, 100-200 mesh).
General procedure for the synthesis of novel chalcones
Equimolar quantity (0.001mol) of 3-acetylpyridine and respective aldehydes were mixed and dissolved in minimum amount of alcohol. To this, 40 % aqueous potassium hydroxide solution (15 ml) was added slowly and mixed occasionally for 24 hrs, at room temperature. Completion of the reaction was identified by TLC using Silica gel-G. After completion of the reaction, the reaction mixture was poured into crushed ice, if necessary acidified with dil.HCl. The solid separated was filtered and dried. It was purified by column chromatography on silica gel (100-200 #, Merck), using ethylacetate and hexane mixture (1:1) as mobile phase. 
Reaction

1-(3'-pyridyl)-3-(3''-nitrophenyl)-2-propen
General procedure for the synthesis of pyrimidines
A mixture of chalcones (obtained by the above method) of 3-acetylpyridine (0.001 mol) and guanidine hydrochloride (0.001 mol) in absolute ethanol (10 ml) were refluxed on a water bath for 6 hours. The solvent was completely evaporated and the residue was poured into ice cold water, the precipitated solid was collected by filtration and crystallized from a suitable solvent to give the desired substituted pyrimidine. 
2-amino-
Antimicrobial activity
The antibacterial activity of synthesized chalcones and their pyrimidine derivatives was conducted against three Gram-positive bacteria viz., Bacillus pumilis, Bacillus subtilis and Staphylococcus aureus and two Gram-negative bacteria viz., Escherichia coli, Proteus vulgaris by using cup plate method. Preparation of nutrient broth, subculture, agar medium and peptone water was done as per standard procedure. Each test compound (5 mg) was dissolved in dimethylsulfoxide (5 ml) to give a concentration of 1000 mg/ml. All the compounds and the standard were tested at 50 µg (0.05 ml) and 100 µg (0.1 ml) dose levels and DMSO used as a control. Ampicillin as standard drug was also prepared at a concentration of 1000 mg/ml in sterilized distilled water.
All the compounds which were screened for antibacterial activity, also screened for their antifungal activity. The fungi employed for screening were Aspergillus niger, Rhizopus oryzae and Candida albicans. Fluconazole was employed as standard to compare the results. The test organisms were sub-cultured using potato-dextrose-agar (PDA) medium.
Each test compound (5mg) was dissolved in dimethylsulfoxide (5ml) to give a concentration of 1000 µg/ml. Fluconazole solution was also prepared at a concentration of 1000 mg/ml in sterilized distilled water. All the compounds and the standard were tested at 50 µg ( 0.05 ml) and 100 µg (0.1 ml) dose levels and DMSO used as a control.
RESULTS AND DISCUSSION
The screening results reveal that all the synthesized novel compounds showed significant antimicrobial activity. Among all the synthesized novel pyrimidine compounds, the novel pyrimidine with 3-nitro substitution (4 e ) exhibited the effective antibacterial and antifungal activities. The standard drugs used were Ampicillin and Fluconazole for antibacterial and antifungal activity respectively.
